3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Carcinoma, Non-Small-Cell Lung
86
Lung Neoplasms
32
Small Cell Lung Carcinoma
18
Melanoma
17
Mesothelioma
13
Neoplasms
11
Colorectal Neoplasms
9
Carcinoma, Renal Cell
9
Squamous Cell Carcinoma of Head and Neck
7
Neoplasm Metastasis
7
Mesothelioma, Malignant
7
Carcinoma, Transitional Cell
7
Ovarian Neoplasms
6
Diabetes Mellitus, Insulin-Dependent, 12
6
Urinary Bladder Neoplasms
5
Triple Negative Breast Neoplasms
5
Pancreatic Neoplasms
5
Liver Neoplasms
5
Endometrial Neoplasms
5
Carcinoma, Hepatocellular
5
Uterine Cervical Neoplasms
4
Stomach Neoplasms
4
Kidney Neoplasms
4
Brain Neoplasms
4
Carcinoma, Merkel Cell
3
Skin Neoplasms
2
Sarcoma
2
Prostatic Neoplasms
2
Lung Diseases
2
Head and Neck Neoplasms
2
Interventions
Tomography, X-Ray Computed
2
Hematologic Tests
2
Blood Specimen Collection
2
tivozanib
1
pembrolizumab
1
aflibercept
1
Videotape Recording
1
Urination
1
Thoracoscopy
1
Thoracic Surgical Procedures
1
Sulfonylurea Compounds
1
Sodium-Glucose Transporter 2 Inhibitors
1
Referral and Consultation
1
Octreotide
1
Magnetic Resonance Spectroscopy
1
Lymph Node Excision
1
Ipilimumab
1
Interviews as Topic
1
Interleukin-15
1
In Situ Hybridization
1
Immunohistochemistry
1
Exercise
1
Erlotinib Hydrochloride
1
Equipment and Supplies
1
Educational Status
1
Dipeptidyl-Peptidase IV Inhibitors
1
Diagnostic Tests, Routine
1
Diagnosis
1
Clinical Laboratory Techniques
1
Bupivacaine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Disease
×
Ipilimumab
×
Thoracic
×
Clear all
NCT04855929
2024-11-08
ANV419-001
Anaveon AG
Phase 1
Completed
55 enrolled